Timothy P. Walbert

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Park Ridge, IL
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Sabrina Nieder, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Timothy P. Walbert

Form 4 holding Director

Kardigan, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
57,573
Estimated value
Report date
17 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

EXICURE, INC.

Security class
Stock Option (right to buy)
Shares / value
50,000
Estimated value
Report date
02 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Odyssey Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
27,393
Estimated value
Report date
07 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Kardigan, Inc.

Security class
Common Stock
Shares / value
20,706
Estimated value
Report date
17 Jun 2026
Price
Ownership
Direct
Form 4 holding Director

Aurinia Pharmaceuticals Inc.

Security class
Stock Option (right to buy)
Shares / value
14,612
Estimated value
Report date
18 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Aurinia Pharmaceuticals Inc.

Security class
Restricted Stock Unit
Shares / value
8,733
Estimated value
Report date
18 May 2022
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Chairman, President and CEO, Director

Horizon Therapeutics Public Ltd Co

Security class
Performance Restricted Stock Units
Shares / value
0
Estimated value
Report date
06 Oct 2023
Price
Ownership
By Spouse
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chairman, President and CEO, Director

Horizon Therapeutics Public Ltd Co

Security class
Performance Restricted Stock Units
Shares / value
0
Estimated value
Report date
06 Oct 2023
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chairman, President and CEO, Director

Horizon Therapeutics Public Ltd Co

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
06 Oct 2023
Price
Ownership
By Spouse
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chairman, President and CEO, Director

Horizon Therapeutics Public Ltd Co

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
06 Oct 2023
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chairman, President and CEO, Director

Horizon Therapeutics Public Ltd Co

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
06 Oct 2023
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Timothy P. Walbert

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .